Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carboplatin

View Patient Information
A second-generation platinum compound with a broad spectrum of antineoplastic properties. Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue. This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic.
Synonym:Carboplatin Hexal
Carboplatino
carboplatinum
US brand name:Paraplatin
Foreign brand name:Blastocarb
Carboplat
Carbosin
Carbosol
Carbotec
Displata
Ercar
Nealorin
Novoplatinum
Paraplatin AQ
Paraplatine
Platinwas
Ribocarbo
Abbreviation:CBDCA
Code name:JM-8
JM8
Chemical structure:(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum
1,1-cyclobutanedicarboxylic acid platinum complex
cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II)
cis-diammine(cyclobutane-1,1-dicarboxylato)platinum
cis-diammine(cyclobutanedicarboxylato)platinum II
platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)
Search NCI's Drug Dictionary